Neurotoxicity Research

, Volume 9, Issue 2–3, pp 149–159

Botulinum toxin for gastrointestinal disorders: Therapy and mechanisms

Article

Abstract

Botulinum toxin has gained widespread acceptance as a treatment option for various spastic gastrointestinal disorders such as achalasia, gastroparesis, sphincter of Oddi dysfunction, chronic anal fissures, and pelvic floor dyssnergia, despite the lack of strong evidence supporting its use in many of these disorders. This review summarizes the trials investigating the use of BoNT since it was first utilized as a treatment in achalasia. BoNT has proven to be safe, but long-term efficacy in many disorders has not been observed, primarily due to is relatively short duration of action. BoNT may be most useful in confirming a diagnosis which can lead to a more definitive treatment modality. Furthermore, its safety profile allows it to be a useful alternative in patients who are at high risk for invasive procedures.

Keywords

Botulinum toxin Achalasia Anal fissure GI spastic disorders 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer 2006

Authors and Affiliations

  1. 1.Enteric Neuromuscular Disorders and Pain (END Pain) Program, Division of Gastroenterology and HepatologyUniversity of Texas Medical BranchGalvestonUSA

Personalised recommendations